SCHEMBL28899732

SCHEMBL28899732

[N-]=[N+]=NC(=Cc1ccc(C(F)(F)F)cc1C(F)(F)F)C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES2 O00748 2/20 0.41
▸ PDE2A O00408 3/20 0.37
▸ LMNA P02545 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ RXRA P19793 1/20 0.34
▸ RXRB P28702 1/20 0.34
▸ RXRG P48443 1/20 0.34
▸ POLQ O75417 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ HPGD P15428 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ ESRRA P11474 1/20 0.32
▸ HCAR1 Q9BXC0 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP3A4 P08684 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ PIM1 P11309 1/20 0.31
▸ PIM2 Q9P1W9 1/20 0.31
▸ PPARA Q07869 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18299918 0.87 CYP1A1 (0.38) CES2PDE2AALDH1A1KDM4EHPGD
SCHEMBL18299914 0.87 CYP1A1 (0.38) CES2PDE2AALDH1A1KDM4EHPGD
SCHEMBL18299915 0.87 CYP1A1 (0.38) CES2PDE2AALDH1A1KDM4EHPGD
SCHEMBL23148082 0.86 PDE2A (0.36) CES2PDE2ALMNAMAPTALDH1A1
SCHEMBL23147718 0.86 HCAR1 (0.32) HCAR1
SCHEMBL28169364 0.83 NPSR1 (0.41) CES2PDE2AMAPTPOLQALDH1A1
SCHEMBL28169406 0.77 POLQ (0.40) CES2PDE2ARXRARXRBRXRG
SCHEMBL19332289 0.75 CTSS (0.38) MAPT
SCHEMBL30262303 0.72 NPSR1 (0.40) PDE2ALMNAMAPTALDH1A1KDM4E
SCHEMBL18307352 0.72 NPSR1 (0.40) PDE2ALMNAMAPTALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107098846-B N-acyl sulfonamide FBPase inhibitor, preparation method thereof, pharmaceutical composition and application thereof 中国医学科学院药物研究所 2020-10-09 — — CN disclosed
Send feedback